Fig. 2From: Development and validation of a new risk assessment model for immunomodulatory drug-associated venous thrombosis among Chinese patients with multiple myelomaVTE incidence and Kaplan‒Meier curves of patients stratified by the new RAM. Abbreviations: HR, hazard ratio; IMiD, immunomodulatory drug; RAM, risk assessment model; VTE, venous thromboembolismBack to article page